Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
SanBio Co Ltd (4592 JP)
Watchlist
46
Analysis
Health Care
•
Japan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SanBio Co Ltd
•
13 Sep 2025 09:00
•
Issuer-paid
SanBio Co Ltd (4592 JP): 1H FY01/26 flash update
In 1H FY01/26, the company reported no operating revenue, with an operating loss of JPY1.9bn and R&D expenses increasing by 31.5%...
Shared Research
Follow
381 Views
Share
bullish
•
SanBio Co Ltd
•
18 Mar 2025 11:00
•
Issuer-paid
SanBio Co Ltd (4592 JP): Full-year FY01/25 flash update
SanBio reported no operating revenue for FY01/25, with an operating loss of JPY3.5bn, narrowing from JPY4.5bn. Non-operating income was JPY628mn,...
Shared Research
Follow
224 Views
Share
bullish
•
SanBio Co Ltd
•
16 Dec 2024 18:00
•
Issuer-paid
SanBio Co Ltd (4592 JP): Q3 FY01/25 flash update
In cumulative Q3 FY01/25, SanBio reported no operating revenue, with an operating loss of JPY2.5bn, narrowing YoY. Non-operating income was...
Shared Research
Follow
269 Views
Share
bullish
•
SanBio Co Ltd
•
17 Sep 2024 18:00
•
Issuer-paid
SanBio Co Ltd (4592 JP): 1H FY01/25 flash update
In 1H FY01/25, the company reported no operating revenue, an operating loss of JPY1.6bn, and R&D expenses of JPY1.0bn. Non-operating income...
Shared Research
Follow
330 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x